Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries 89Bio Inc (NQ: ETNB ) 9.140 +1.360 (+17.48%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,993,853 Open 7.820 Bid (Size) 8.490 (1) Ask (Size) 9.500 (2) Prev. Close 7.780 Today's Range 7.670 - 9.500 52wk Range 6.880 - 16.63 Shares Outstanding 75,480,884 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH November 01, 2024 Madrigal sells an approved MASH treatment that blasted third-quarter sales views out of the water. Via Investor's Business Daily 89bio to Present New Analyses from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at AASLD The Liver Meeting® 2024 October 15, 2024 From 89bio, Inc. Via GlobeNewswire Performance YTD -19.04% -19.04% 1 Month +27.65% +27.65% 3 Month +8.94% +8.94% 6 Month -4.69% -4.69% 1 Year +8.68% +8.68% More News Read More 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) October 11, 2024 From 89bio, Inc. Via GlobeNewswire ETNB Stock Earnings: 89bio Beats EPS for Q2 2024 August 05, 2024 Via InvestorPlace ETNB Stock Earnings: 89bio Misses EPS for Q1 2024 May 09, 2024 Via InvestorPlace 89bio to Participate in the H.C. Wainwright 8th Annual MASH Investor Conference September 30, 2024 From 89bio, Inc. Via GlobeNewswire 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) September 19, 2024 From 89bio, Inc. Via GlobeNewswire 89bio Announces Appointment of Teresa Perney, Ph.D. as Chief Regulatory and Quality Officer September 16, 2024 From 89bio, Inc. Via GlobeNewswire 89bio to Participate in Upcoming Investor Conferences August 29, 2024 From 89bio, Inc. Via GlobeNewswire 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 09, 2024 From 89bio, Inc. Via GlobeNewswire 89bio Appoints Francis Sarena as Chief Operating Officer August 07, 2024 From 89bio, Inc. Via GlobeNewswire 89bio Reports Second Quarter 2024 Financial Results and Corporate Updates August 05, 2024 From 89bio, Inc. Via GlobeNewswire 89bio Appoints Charles McWherter, Ph.D., to its Board of Directors August 05, 2024 From 89bio, Inc. Via GlobeNewswire 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 12, 2024 From 89bio, Inc. Via GlobeNewswire 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 14, 2024 From 89bio, Inc. Via GlobeNewswire What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday? June 05, 2024 Via Benzinga Madrigal, Akero, 89bio Tumble After Lilly's Weight-Loss Drug Tackles MASH June 05, 2024 Via Investor's Business Daily The Week Ahead: What's Next June 02, 2024 Via Talk Markets 89bio to Present 48-Week Data from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at EASL International Liver Congress May 22, 2024 From 89bio, Inc. Via GlobeNewswire 89bio Initiates Phase 3 ENLIGHTEN-Cirrhosis Trial of Pegozafermin in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Patients with Compensated Cirrhosis May 14, 2024 From 89bio, Inc. Via GlobeNewswire 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 10, 2024 From 89bio, Inc. Via GlobeNewswire 89bio Reports First Quarter 2024 Financial Results and Provides Corporate Update May 09, 2024 From 89bio, Inc. Via GlobeNewswire 89bio to Participate in the BofA Securities 2024 Health Care Conference May 08, 2024 From 89bio, Inc. Via GlobeNewswire 89bio to Host Key Opinion Leader Webinar on Pegozafermin’s Opportunity in Advanced MASH May 02, 2024 From 89bio, Inc. Via GlobeNewswire 89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors April 17, 2024 From 89bio, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
